Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Conditional Survival Of Patients With Limited-stage Small Cell Lung Cancer After Surgery: A National Real-world Cohort Study.

Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study.

Jun-Peng Lin1,2,3, Xiao-Feng Chen1,2,3, Peiyuan Wang1,2,3

  • 1Department of Thoracic Oncology Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

Annals of Surgical Oncology
|February 9, 2024

Related Experiment Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

268
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

View abstract on PubMed

Summary
This summary is machine-generated.

Prognosis for limited-stage small cell lung cancer (LS-SCLC) improves significantly over time, especially for advanced stages. Age and surgery type are key factors influencing long-term survival in LS-SCLC patients.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Cancer Epidemiology

Background:

  • Prognosis for limited-stage small cell lung cancer (LS-SCLC) is typically estimated at diagnosis.
  • The evolution of prognosis over time for LS-SCLC patients surviving a predefined period remains unclear.

Purpose of the Study:

  • To investigate the dynamic changes in prognosis for LS-SCLC patients post-surgery.
  • To analyze conditional survival rates and identify prognostic factors over time.

Main Methods:

  • Utilized data from the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015).
  • Calculated 5-year conditional cancer-specific survival (CCSS) and conditional overall survival (COS).
  • Analyzed 997 patients diagnosed with LS-SCLC post-surgery.
Keywords:
Conditional cancer-specific survivalConditional overall survivalLimited-stage small cell lung cancerPrognosis

Related Experiment Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

268
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

Main Results:

  • 5-year CCSS and COS increased from diagnosis (44.7%, 38.3%) to 5 years post-diagnosis (83.7%, 67.9%).
  • Survival gaps between initial stages narrowed significantly over time, with similar rates after 5 years.
  • Lobectomy was associated with better conditional survival compared to sublobectomy or pneumonectomy.

Conclusions:

  • Conditional survival estimates for LS-SCLC show a general increase over time, particularly for advanced stages.
  • Resection type and older age are significant independent predictors of prognosis.
  • These findings highlight the importance of dynamic survival assessment in LS-SCLC management.